{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:27:55Z","timestamp":1777998475725,"version":"3.51.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recent studies have demonstrated the critical role of IL-10 in susceptibility to cutaneous and visceral leishmaniasis caused by Leishmania major and Leishmania donovani, respectively. To determine whether IL-10 also plays a similar role in the susceptibility and pathogenesis of cutaneous leishmaniasis caused by the New World species, L. mexicana and L. amazonensis, we analyzed their course of infection in IL-10-deficient BALB\/c mice and their wild-type counterparts. Although IL-10-deficient mice infected with either L. mexicana or L. amazonensis failed to control the lesion progression, we did observe consistently lower levels of infection in IL-10\u2212\/\u2212 mice compared with wild-type BALB\/c mice. We also observed increased IFN-\u03b3 and NO production and higher levels for IL-12p40 and IL-12R\u03b22 mRNA in cells from IL-10\u2212\/\u2212 mice compared with cells from BALB\/c mice. The mRNA levels for IL-4, which increased significantly in both IL-10\u2212\/\u2212 and BALB\/c mice, were comparable. When treated with anti-IL-4 mAb, IL-10\u2212\/\u2212 mice resolved the infection more effectively and had significantly fewer parasites in their lesions compared with similarly treated BALB\/c mice. These findings suggest that IL-10, although not the dominant mediator of susceptibility of BALB\/c mice to infection with L. mexicana and L. amazonensis, does play a significant role in regulating the development of a protective Th1-type response. However, effective resolution of infection with these New World parasites requires neutralization of both IL-4 and IL-10.<\/jats:p>","DOI":"10.4049\/jimmunol.171.7.3705","type":"journal-article","created":{"date-parts":[[2014,4,20]],"date-time":"2014-04-20T23:19:35Z","timestamp":1398035975000},"page":"3705-3710","source":"Crossref","is-referenced-by-count":93,"title":["The Role of Interleukin-10 in Susceptibility of BALB\/c Mice to Infection with\n                    <i>Leishmania mexicana<\/i>\n                    and\n                    <i>Leishmania amazonensis<\/i>"],"prefix":"10.1093","volume":"171","author":[{"given":"Udaikumar M","family":"Padigel","sequence":"first","affiliation":[{"name":"Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania , Philadelphia, PA 19104"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Strathclyde, Strathclyde Institute for Biomedical Sciences , Glasgow ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay P","family":"Farrell","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania , Philadelphia, PA 19104"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2003,10,1]]},"reference":[{"key":"2026020210171883200_R1","first-page":"7011","volume-title":"Proc. Natl. Acad. Sci. USA","year":"1991"},{"key":"2026020210171883200_R2","first-page":"1675","volume-title":"J. Exp. Med.","year":"1988"},{"key":"2026020210171883200_R3","first-page":"1127","volume-title":"J. Exp. Med.","year":"1996"},{"key":"2026020210171883200_R4","first-page":"6132","volume-title":"J. Immunol.","year":"1999"},{"key":"2026020210171883200_R5","first-page":"60","volume-title":"Chem. Immunol.","year":"1998"},{"key":"2026020210171883200_R6","first-page":"2993","volume-title":"J. Cell Sci.","year":"1999"},{"key":"2026020210171883200_R7","first-page":"178","volume-title":"Am. J. Trop. Med. Hyg.","year":"1996"},{"key":"2026020210171883200_R8","first-page":"2952","volume-title":"Infect. Immun.","year":"1993"},{"key":"2026020210171883200_R9","first-page":"5005","volume-title":"J. Immunol.","year":"1997"},{"key":"2026020210171883200_R10","first-page":"89","volume-title":"J. Immunogenet.","year":"1990"},{"key":"2026020210171883200_R11","first-page":"364","volume-title":"J. Immunol.","year":"2000"},{"key":"2026020210171883200_R12","first-page":"3206","volume-title":"Eur. J. Immunol.","year":"2002"},{"key":"2026020210171883200_R13","first-page":"545","volume-title":"Science","year":"1992"},{"key":"2026020210171883200_R14","first-page":"115","volume-title":"J. Exp. Med.","year":"1990"},{"key":"2026020210171883200_R15","first-page":"2923","volume-title":"Eur. J. Immunol.","year":"2002"},{"key":"2026020210171883200_R16","first-page":"1141","volume-title":"J. Immunol.","year":"2001"},{"key":"2026020210171883200_R17","first-page":"2151","volume-title":"Infect. Immun.","year":"2002"},{"key":"2026020210171883200_R18","first-page":"151","volume-title":"J. Immunol. Methods","year":"1989"},{"key":"2026020210171883200_R19","first-page":"131","volume-title":"Anal. Biochem.","year":"1982"},{"key":"2026020210171883200_R20","first-page":"1675","volume-title":"Infect. Immun.","year":"1997"},{"key":"2026020210171883200_R21","first-page":"324","volume-title":"J. Clin. Invest.","year":"1993"},{"key":"2026020210171883200_R22","first-page":"64","volume-title":"Clin. Exp. Immunol.","year":"1998"},{"key":"2026020210171883200_R23","first-page":"3311","volume-title":"J. Immunol.","year":"1997"},{"key":"2026020210171883200_R24","first-page":"2763","volume-title":"J. Immunol.","year":"1991"},{"key":"2026020210171883200_R25","first-page":"1687","volume-title":"J. Infect. Dis.","year":"1998"},{"key":"2026020210171883200_R26","first-page":"1723","volume-title":"J. Immunol.","year":"1999"},{"key":"2026020210171883200_R27","first-page":"1497","volume-title":"J. Exp. Med.","year":"2001"},{"key":"2026020210171883200_R28","first-page":"2848","volume-title":"Eur. J. Immunol.","year":"2001"},{"key":"2026020210171883200_R29","first-page":"6284","volume-title":"Infect. Immun.","year":"2002"},{"key":"2026020210171883200_R30","first-page":"153","volume-title":"Cell. Immunol.","year":"1996"},{"key":"2026020210171883200_R31","first-page":"6370","volume-title":"J. Immunol.","year":"1993"},{"key":"2026020210171883200_R32","first-page":"2898","volume-title":"J. Immunol.","year":"1997"},{"key":"2026020210171883200_R33","first-page":"5152","volume-title":"J. Immunol.","year":"2003"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/171\/7\/3705\/62589479\/3705.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/171\/7\/3705\/62589479\/3705.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:22:43Z","timestamp":1770045763000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/171\/7\/3705\/8030730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2003,10,1]]},"published-print":{"date-parts":[[2003,10,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.171.7.3705","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2003,10]]},"published":{"date-parts":[[2003,10,1]]}}}